Abstract
Breast cancer is the most frequently diagnosed cancer and also one of the leading causes of mortality among women. The genetic and environmental factors known to date do not fully explain the risk of developing this disease. In recent years, numerous studies have highlighted the dual role of the gut microbiota in the preservation of host health and in the development of different pathologies, cancer among them. Our gut microbiota is capable of producing metabolites that protect host homeostasis but can also produce molecules with deleterious effects, which, in turn, may trigger inflammation and carcinogenesis, and even affect immunotherapy. The purpose of this review is to describe the mechanisms by which the gut microbiota may cause cancer in general, and breast cancer in particular, and to compile clinical trials that address alterations or changes in the microbiota of women with breast cancer.
Reference101 articles.
1. Álvarez-Mercado, A., Navarro-Oliveros, M., Robles-Sánchez, C., Plaza-Díaz, J., Sáez-Lara, M., Muñoz-Quezada, S., Fontana, L., and Abadía-Molina, F. (2019). Microbial Population Changes and Their Relationship with Human Health and Disease. Microorganisms, 7.
2. Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G.L., Tonini, G., and Libra, M. (2019). Gut microbiota and cancer: From pathogenesis to therapy. Cancers, 11.
3. International Agency for Research on Cancer 2020;Ferlay;Glob. Cancer Obs. Cancer Today.,2020
4. Cancer statistics for the year 2020: An overview;Ferlay;Int. J. Cancer,2021
5. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis;Georges;Lancet Glob. Health,2020
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献